ConductScience.org, home

Paper3918869

Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Carrel S and 2 others. Eur J Immunol, 1985. Cited by 142 papers, by iCite.

Cite this record

ConductScience Library. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens. Papers, record 3918869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3918869

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
PubMed
Journal
Eur J Immunol
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
142
iCite
Relative citation ratio, by iCite
3.61
iCite
Revised in PubMed
2020-12-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Carrel SS
2Schmidt-Kessen AA
3Giuffrè LL

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HLA AntigensMajor topic
Histocompatibility Antigens Class IIMajor topic
Interferon-gammaMajor topic
Cell Line
Cell Membrane
Colonic Neoplasms
DNA, Recombinant
Dose-Response Relationship, Drug
Glioma
HLA-DQ Antigens
HLA-DR Antigens
Humans
Interferon Type I
Melanoma
Molecular Weight
beta 2-Microglobulin

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.

PMIDTitleJournalYearIn PapersSource
39956823Identification and characterization of cell niches in tissue from spatial omics data at single-cell resolution.Nat Commun2025https://conductscience.org/library/papers/39956823PubMed
30193111A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging.Cell2018https://conductscience.org/library/papers/30193111PubMed
27141382Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion.Oncoimmunology2016https://conductscience.org/library/papers/27141382PubMed
22358536Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells.Cytotechnology1997https://conductscience.org/library/papers/22358536PubMed
12679797A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.Cancer Gene Ther2003https://conductscience.org/library/papers/12679797PubMed
11839572Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.Am J Pathol2002https://conductscience.org/library/papers/11839572PubMed
11083492The treatment of established intracranial tumors by in situ retroviral IFN-gamma transfer.Gene Ther2000https://conductscience.org/library/papers/11083492PubMed
8422663Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8422663PubMed
8270604Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/8270604PubMed
8124687MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8124687PubMed
8101473Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8101473PubMed
7917907Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.Br J Cancer1994https://conductscience.org/library/papers/7917907PubMed
7488605Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.Br J Ophthalmol1995https://conductscience.org/library/papers/7488605PubMed
3862745Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.J Exp Med1985https://conductscience.org/library/papers/3862745PubMed
3779716BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors?Cancer Immunol Immunother1986https://conductscience.org/library/papers/3779716PubMed
3664532Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3664532PubMed
3132343IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.Clin Exp Metastasis1988https://conductscience.org/library/papers/3132343PubMed
3124997
Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
Clin Exp Immunol1987https://conductscience.org/library/papers/3124997PubMed
3117460HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.Clin Exp Immunol1987https://conductscience.org/library/papers/3117460PubMed
3114551[Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].Klin Wochenschr1987https://conductscience.org/library/papers/3114551PubMed

See all 30 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3918869

GET https://conductscience.org/api/papers/v1/3918869/cited_by?page=2